Vitamin D, vitamin D receptor and tissue barriers

References

• Demay MB. Mechanism of vitamin D receptor action. Ann N Y Acad Sci 2006; 1068:204 - 13; http://dx.doi.org/10.1196/annals.1346.026; PMID: 16831920
   PubMed Web of Science ®Google Scholar
• Haussler MR, Whitfield GK, Haussler CA, Hsieh J-C, Thompson PD, Selznick SH, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998; 13:325 - 49; http://dx.doi.org/10.1359/jbmr.1998.13.3.325; PMID: 9525333
   PubMed Web of Science ®Google Scholar
• Wang Y, Becklund BR, DeLuca HF. Identification of a highly specific and versatile vitamin D receptor antibody. Arch Biochem Biophys 2010; 494:166 - 77; http://dx.doi.org/10.1016/j.abb.2009.11.029; PMID: 19951695
   PubMedGoogle Scholar
• Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29:726 - 76; http://dx.doi.org/10.1210/er.2008-0004; PMID: 18694980
   PubMed Web of Science ®Google Scholar
• Carlberg C, Seuter S. A genomic perspective on vitamin D signaling. Anticancer Res 2009; 29:3485 - 93; PMID: 19667142
   PubMed Web of Science ®Google Scholar
• Bikle DD. Vitamin D and the skin: Physiology and pathophysiology. Rev Endocr Metab Disord 2012; 13:3 - 19; http://dx.doi.org/10.1007/s11154-011-9194-0; PMID: 21845365
   PubMedGoogle Scholar
• Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7:684 - 700; http://dx.doi.org/10.1038/nrc2196; PMID: 17721433
   PubMed Web of Science ®Google Scholar
• Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann N Y Acad Sci 2009; 1173:384 - 90; http://dx.doi.org/10.1111/j.1749-6632.2009.04875.x; PMID: 19758177
   PubMed Web of Science ®Google Scholar
• Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4:404 - 12; http://dx.doi.org/10.1038/ncprheum0855; PMID: 18594491
   PubMedGoogle Scholar
• Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, et al. Vitamin D, calcium supplementation and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003; 95:1765 - 71; http://dx.doi.org/10.1093/jnci/djg110; PMID: 14652238
   PubMed Web of Science ®Google Scholar
• Gocek E, Studzinski GP. Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci 2009; 46:190 - 209; http://dx.doi.org/10.1080/10408360902982128; PMID: 19650715
   PubMed Web of Science ®Google Scholar
• Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008; 3:1535 - 41; http://dx.doi.org/10.2215/CJN.01160308; PMID: 18525006
   PubMed Web of Science ®Google Scholar
• Cannell JJ, Hollis BW, Zasloff M, Heaney RP. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2008; 9:107 - 18; http://dx.doi.org/10.1517/14656566.9.1.107; PMID: 18076342
   PubMed Web of Science ®Google Scholar
• Campbell FC, Xu H, El-Tanani M, Crowe P, Bingham V. The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem Pharmacol 2010; 79:1 - 9; http://dx.doi.org/10.1016/j.bcp.2009.09.005; PMID: 19737544
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 2007; 13:4042 - 5; http://dx.doi.org/10.1158/1078-0432.CCR-06-2316; PMID: 17634527
   PubMed Web of Science ®Google Scholar
• Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010; 138:2101 - 14.e5; http://dx.doi.org/10.1053/j.gastro.2010.01.058; PMID: 20420949
   PubMed Web of Science ®Google Scholar
• Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275:1787 - 90; http://dx.doi.org/10.1126/science.275.5307.1787; PMID: 9065402
   PubMed Web of Science ®Google Scholar
• Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, et al. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell 2006; 21:799 - 809; http://dx.doi.org/10.1016/j.molcel.2006.01.037; PMID: 16543149
   PubMed Web of Science ®Google Scholar
• Haussler MR, Haussler CA, Whitfield GK, Hsieh JC, Thompson PD, Barthel TK, et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging. J Steroid Biochem Mol Biol 2010; 121:88 - 97; http://dx.doi.org/10.1016/j.jsbmb.2010.03.019; PMID: 20227497
   PubMed Web of Science ®Google Scholar
• Pendás-Franco N, Aguilera O, Pereira F, González-Sancho JM, Muñoz A. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res 2008; 28:5A 2613 - 23; PMID: 19035286
   PubMed Web of Science ®Google Scholar
• Larriba MJ, Valle N, Pálmer HG, Ordóñez-Morán P, Alvarez-Díaz S, Becker KF, et al. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells. Endocr Relat Cancer 2007; 14:141 - 51; http://dx.doi.org/10.1677/ERC-06-0028; PMID: 17395983
   PubMedGoogle Scholar
• Pálmer HG, González-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001; 154:369 - 87; http://dx.doi.org/10.1083/jcb.200102028; PMID: 11470825
   PubMed Web of Science ®Google Scholar
• Furuse M. Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol 2010; 2:a002907; http://dx.doi.org/10.1101/cshperspect.a002907; PMID: 20182608
   PubMed Web of Science ®Google Scholar
• Migliori M, Giovannini L, Panichi V, Filippi C, Taccola D, Origlia N, et al. Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis. Int J Immunopathol Pharmacol 2005; 18:779 - 90; PMID: 16388728
   PubMed Web of Science ®Google Scholar
• Yin Z, Pintea V, Lin Y, Hammock BD, Watsky MA. Vitamin D enhances corneal epithelial barrier function. Invest Ophthalmol Vis Sci 2011; 52:7359 - 64; http://dx.doi.org/10.1167/iovs.11-7605; PMID: 21715350
   PubMed Web of Science ®Google Scholar
• Fujita H, Sugimoto K, Inatomi S, Maeda T, Osanai M, Uchiyama Y, et al. Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol Biol Cell 2008; 19:1912 - 21; http://dx.doi.org/10.1091/mbc.E07-09-0973; PMID: 18287530
   PubMed Web of Science ®Google Scholar
• Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294:G208 - 16; http://dx.doi.org/10.1152/ajpgi.00398.2007; PMID: 17962355
   PubMed Web of Science ®Google Scholar
• Zeissig S, Bürgel N, Günzel D, Richter J, Mankertz J, Wahnschaffe U, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut 2007; 56:61 - 72; http://dx.doi.org/10.1136/gut.2006.094375; PMID: 16822808
   PubMed Web of Science ®Google Scholar
• Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, Amasheh S, et al. Claudin-2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 2010; 123:1913 - 21; http://dx.doi.org/10.1242/jcs.060665; PMID: 20460438
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Fromm M. Tight junctions: molecular structure meets function. Ann N Y Acad Sci 2009; 1165:1 - 6; http://dx.doi.org/10.1111/j.1749-6632.2009.04925.x; PMID: 19538280
   PubMed Web of Science ®Google Scholar
• Van Itallie CM, Holmes J, Bridges A, Anderson JM. Claudin-2-dependent changes in noncharged solute flux are mediated by the extracellular domains and require attachment to the PDZ-scaffold. Ann N Y Acad Sci 2009; 1165:82 - 7; http://dx.doi.org/10.1111/j.1749-6632.2009.04052.x; PMID: 19538292
   PubMedGoogle Scholar
• Holmes JL, Van Itallie CM, Rasmussen JE, Anderson JM. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 2006; 6:581 - 8; http://dx.doi.org/10.1016/j.modgep.2005.12.001; PMID: 16458081
   PubMed Web of Science ®Google Scholar
• Christakos S, Dhawan P, Ajibade D, Benn BS, Feng J, Joshi SS. Mechanisms involved in vitamin D mediated intestinal calcium absorption and in non-classical actions of vitamin D. J Steroid Biochem Mol Biol 2010; 121:183 - 7; http://dx.doi.org/10.1016/j.jsbmb.2010.03.005; PMID: 20214989
   PubMed Web of Science ®Google Scholar
• Hartmann B, Riedel R, Jörss K, Loddenkemper C, Steinmeyer A, Zügel U, et al. Vitamin D receptor activation improves allergen-triggered eczema in mice. J Invest Dermatol 2012; 132:330 - 6; http://dx.doi.org/10.1038/jid.2011.296; PMID: 21938012
   PubMed Web of Science ®Google Scholar
• Hollander D. Crohn’s disease--a permeability disorder of the tight junction?. Gut 1988; 29:1621 - 4; http://dx.doi.org/10.1136/gut.29.12.1621; PMID: 3065154
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, et al. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 2009; 1165:294 - 300; http://dx.doi.org/10.1111/j.1749-6632.2009.04062.x; PMID: 19538319
   PubMed Web of Science ®Google Scholar
• Ivanov AI, Nusrat A, Parkos CA. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 2004; 263:115 - 24, discussion 124-32, 211-8; http://dx.doi.org/10.1002/0470090480.ch9; PMID: 15669638
   PubMedGoogle Scholar
• Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest 2008; 88:1110 - 20; http://dx.doi.org/10.1038/labinvest.2008.78; PMID: 18711353
   PubMed Web of Science ®Google Scholar
• Arnott ID, Kingstone K, Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol 2000; 35:1163 - 9; http://dx.doi.org/10.1080/003655200750056637; PMID: 11145287
   PubMed Web of Science ®Google Scholar
• Wyatt J, Vogelsang H, Hübl W, Waldhöer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet 1993; 341:1437 - 9; http://dx.doi.org/10.1016/0140-6736(93)90882-H; PMID: 8099141
   PubMed Web of Science ®Google Scholar
• Laukoetter MG, Nava P, Lee WY, Severson EA, Capaldo CT, Babbin BA, et al. JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med 2007; 204:3067 - 76; http://dx.doi.org/10.1084/jem.20071416; PMID: 18039951
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhang H, Wu H, Li H, Liu L, Guo J, et al. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol 2012; 12:57; http://dx.doi.org/10.1186/1471-230X-12-57; PMID: 22647055
   PubMed Web of Science ®Google Scholar
• Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB, et al. Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol 2010; 177:686 - 97; http://dx.doi.org/10.2353/ajpath.2010.090998; PMID: 20566739
   PubMed Web of Science ®Google Scholar
• Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol 2010; 26:591 - 5; http://dx.doi.org/10.1097/MOG.0b013e32833d4b9f; PMID: 20639756
   PubMed Web of Science ®Google Scholar
• Agrawal T, Gupta GK, Agrawal DK. Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation. Exp Mol Pathol 2012; 93:74 - 81; http://dx.doi.org/10.1016/j.yexmp.2012.04.004; PMID: 22537547
   PubMed Web of Science ®Google Scholar
• Finklea JD, Grossmann RE, Tangpricha V. Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv Nutr 2011; 2:244 - 53; http://dx.doi.org/10.3945/an.111.000398; PMID: 22332056
   PubMed Web of Science ®Google Scholar
• Mak G, Hanania NA. Vitamin D and asthma. Curr Opin Pulm Med 2011; 17:1 - 5; http://dx.doi.org/10.1097/MCP.0b013e3283411440; PMID: 21045696
   PubMed Web of Science ®Google Scholar
• Zosky GR, Berry LJ, Elliot JG, James AL, Gorman S, Hart PH. Vitamin D deficiency causes deficits in lung function and alters lung structure. Am J Respir Crit Care Med 2011; 183:1336 - 43; http://dx.doi.org/10.1164/rccm.201010-1596OC; PMID: 21297070
   PubMed Web of Science ®Google Scholar
• Finklea JD, Grossmann RE, Tangpricha V. Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv Nutr 2011; 2:244 - 53; http://dx.doi.org/10.3945/an.111.000398; PMID: 22332056
   PubMed Web of Science ®Google Scholar
• Sundar IK, Hwang JW, Wu S, Sun J, Rahman I. Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation. Biochem Biophys Res Commun 2011; 406:127 - 33; http://dx.doi.org/10.1016/j.bbrc.2011.02.011; PMID: 21300024
   PubMed Web of Science ®Google Scholar
• Laverny G, Penna G, Vetrano S, Correale C, Nebuloni M, Danese S, et al. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol Lett 2010; 131:49 - 58; http://dx.doi.org/10.1016/j.imlet.2010.03.006; PMID: 20350569
   PubMed Web of Science ®Google Scholar
• Goff JP, Koszewski NJ, Haynes JS, Horst RL. Targeted delivery of vitamin D to the colon using β-glucuronides of vitamin D: therapeutic effects in a murine model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2012; 302:G460 - 9; http://dx.doi.org/10.1152/ajpgi.00156.2011; PMID: 22114117
   PubMed Web of Science ®Google Scholar
• Miheller P, Muzes G, Hritz I, Lakatos G, Pregun I, Lakatos PL, et al. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn’s disease patients. Inflamm Bowel Dis 2009; 15:1656 - 62; http://dx.doi.org/10.1002/ibd.20947; PMID: 19408329
   PubMed Web of Science ®Google Scholar
• Valdivielso JM, Cannata-Andía J, Coll B, Fernández E. A new role for vitamin D receptor activation in chronic kidney disease. Am J Physiol Renal Physiol 2009; 297:F1502 - 9; http://dx.doi.org/10.1152/ajprenal.00130.2009; PMID: 19625376
   PubMedGoogle Scholar
• Naves-Díaz M, Alvarez-Hernández D, Passlick-Deetjen J, Guinsburg A, Marelli C, Rodriguez-Puyol D, et al. Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int 2008; 74:1070 - 8; http://dx.doi.org/10.1038/ki.2008.343; PMID: 18633342
   PubMed Web of Science ®Google Scholar
• Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr., et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16:1115 - 25; http://dx.doi.org/10.1681/ASN.2004070573; PMID: 15728786
   PubMed Web of Science ®Google Scholar
• Dombrowski Y, Peric M, Koglin S, Ruzicka T, Schauber J. Control of cutaneous antimicrobial peptides by vitamin D3. Arch Dermatol Res 2010; 302:401 - 8; http://dx.doi.org/10.1007/s00403-010-1045-4; PMID: 20221619
   PubMed Web of Science ®Google Scholar
• Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 2005; 19:1067 - 77; http://dx.doi.org/10.1096/fj.04-3284com; PMID: 15985530
   PubMed Web of Science ®Google Scholar
• Muehleisen B, Bikle DD, Aguilera C, Burton DW, Sen GL, Deftos LJ, et al. PTH/PTHrP and vitamin D control antimicrobial peptide expression and susceptibility to bacterial skin infection. Sci Transl Med 2012; 4:35ra66; http://dx.doi.org/10.1126/scitranslmed.3003759; PMID: 22623742
   PubMedGoogle Scholar
• Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008; 122:829 - 31; http://dx.doi.org/10.1016/j.jaci.2008.08.020; PMID: 19014773
   PubMed Web of Science ®Google Scholar
• Heilborn JD, Weber G, Grönberg A, Dieterich C, Ståhle M. Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18/LL-37 during wounding in human skin in vivo. Exp Dermatol 2010; 19:332 - 8; http://dx.doi.org/10.1111/j.1600-0625.2009.00997.x; PMID: 19878298
   PubMed Web of Science ®Google Scholar
• Peric M, Koglin S, Dombrowski Y, Gross K, Bradac E, Büchau A, et al. Vitamin D analogs differentially control antimicrobial peptide/”alarmin” expression in psoriasis. PLoS One 2009; 4:e6340; http://dx.doi.org/10.1371/journal.pone.0006340; PMID: 19623255
   PubMed Web of Science ®Google Scholar
• Ma JX, Xia JB, Cheng XM, Wang CZ. 1,25-dihydroxyvitamin D₃ pretreatment enhances the efficacy of allergen immunotherapy in a mouse allergic asthma model. Chin Med J (Engl) 2010; 123:3591 - 6; PMID: 22166637
   PubMed Web of Science ®Google Scholar
• Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377:242 - 50; http://dx.doi.org/10.1016/S0140-6736(10)61889-2; PMID: 21215445
   PubMed Web of Science ®Google Scholar
• Slominski AT, Kim TK, Janjetovic Z, Tuckey RC, Bieniek R, Yue J, et al. 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. Am J Physiol Cell Physiol 2011; 300:C526 - 41; http://dx.doi.org/10.1152/ajpcell.00203.2010; PMID: 21160030
   PubMed Web of Science ®Google Scholar
• Slominski AT, Kim TK, Chen J, Nguyen MN, Li W, Yates CR, et al. Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes. Int J Biochem Cell Biol 2012; 44:2003 - 18; http://dx.doi.org/10.1016/j.biocel.2012.07.027; PMID: 22877869
   PubMed Web of Science ®Google Scholar
• Slominski AT, Kim TK, Shehabi HZ, Semak I, Tang EK, Nguyen MN, et al. In vivo evidence for a novel pathway of vitamin D₃ metabolism initiated by P450scc and modified by CYP27B1. FASEB J 2012; 26:3901 - 15; http://dx.doi.org/10.1096/fj.12-208975; PMID: 22683847
   PubMed Web of Science ®Google Scholar
• Ordóñez-Morán P, Alvarez-Díaz S, Valle N, Larriba MJ, Bonilla F, Muñoz A. The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling. J Steroid Biochem Mol Biol 2010; 121:355 - 61; http://dx.doi.org/10.1016/j.jsbmb.2010.02.031; PMID: 20223287
   PubMedGoogle Scholar
• Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, et al. Molecular Mechanisms of Vitamin D Action. Calcif Tissue Int 2012; http://dx.doi.org/10.1007/s00223-012-9619-0; PMID: 22782502
   PubMedGoogle Scholar
• Pereira F, Barbáchano A, Silva J, Bonilla F, Campbell MJ, Muñoz A, et al. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum Mol Genet 2011; 20:4655 - 65; http://dx.doi.org/10.1093/hmg/ddr399; PMID: 21890490
   PubMed Web of Science ®Google Scholar